LORTUSSEX (Sallus Laboratories, LLC)


Welcome to the PulseAid listing for the LORTUSS drug offered from Sallus Laboratories, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Sallus Laboratories, LLC
NON-PROPRIETARY NAME: Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride
SUBSTANCE NAME: CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2014-06-01
END MARKETING DATE: 0000-00-00


LORTUSS EX HUMAN OTC DRUG Details:

Item DescriptionLORTUSS EX from Sallus Laboratories, LLC
LABELER NAME: Sallus Laboratories, LLC
DEA SCHEDULE: CV
ACTIVE STRENGTH: 10; 100; 30(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2014-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69036-130_ec543c14-8427-4659-bcc0-3cdcd149ba81
PRODUCT NDC: 69036-130
APPLICATION NUMBER: part341

Other CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Glendale IncCoditussin DAC
Llorens Pharmaceutical International DivisionTusnel
Respa Pharmaceuticals, Inc.Tricode
Sallus Laboratories, LLCLORTUSS
Virtus PharmaceuticalsVirtussin DAC